stockportfolio.pro
Stocks / ARDT vs BCAX
ARDT vs BCAX
Ardent Health, Inc. and Bicara Therapeutics Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Ardent Health, Inc. (ARDT) | Bicara Therapeutics Inc. (BCAX) | |
|---|---|---|
| Market cap | $1.4B | $1.4B |
| Revenue (latest FY) | $6.32B | $0 |
| Net income (latest FY) | $135.81M | $-137.95M |
| Revenue growth (5y CAGR) | 7.2% | — |
| Net margin | 2.1% | — |
| Return on equity | 8.1% | -34.4% |
| P/E ratio | 9.9 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 4 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ARDT — free Open BCAX — freeFrequently asked questions
Which is bigger, ARDT or BCAX?
Bicara Therapeutics Inc. is larger by market capitalization — $1.4B versus $1.4B.
Which grows faster, ARDT or BCAX?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.